Article

SOX2-induced IL-1alpha-mediated immune suppression drives epithelial dysplasia malignant…

medRxiv · 2024 · Taner, H. F.; Gong, W.; Fitzsimonds, Z. R.; Li, Z.; Wu, Y.; He, Y.; Okuyama, K.; Cheng, W.; Kuczura, J.; Rajesh, S.; Manousidaki, A.; Feng, S.; Lee, M.; Nor, F.; Lanzel, E.; Demehri, S.; Polverini, P.; Nor, J.; Wang, T.; Que, J.; Wen, H.; Xie, Y.; Moon, J.; Lei, Y. L.

Key facts

Title SOX2-induced IL-1alpha-mediated immune suppression drives epithelial dysplasia malignant transformation
First author Taner, H. F.; Gong, W.; Fitzsimonds, Z. R.; Li, Z.; Wu, Y.; He, Y.; Okuyama, K.; Cheng, W.; Kuczura, J.; Rajesh, S.; Manousidaki, A.; Feng, S.; Lee, M.; Nor, F.; Lanzel, E.; Demehri, S.; Polverini, P.; Nor, J.; Wang, T.; Que, J.; Wen, H.; Xie, Y.; Moon, J.; Lei, Y. L.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.12.06.626475
Devices mentioned BK110039, DEN000008, K022086, K103302
Product codes mentioned JCI, JJH, KIT, MVU, NDS, NJT, OOI, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature